Measures of disease activity and damage in pediatric systemic lupus erythematosus: British Isles Lupus Assessment Group (BILAG), European Consensus Lupus Activity Measurement (ECLAM), Systemic Lupus Activity Measure (SLAM), Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), Physician's Global Assessment of Disease Activity (MD Global), and Systemic Lupus International Collaborating

Arthritis Care and Research

Volumn 63, Issue SUPPL. 11, 2011, Pages

  Lattanzi, Bianca ^a,b   Consolaro, Alessandro ^a,b   Solari, Nicoletta ^a,b   Ruperto, Nicolino ^a   Martini, Alberto ^a,b   Ravelli, Angelo ^a,b  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTHRALGIA; ARTICLE; CHILDHOOD DISEASE; CLINICAL ASSESSMENT; DISEASE ACTIVITY; FATIGUE; FOLLOW UP; HUMAN; MYALGIA; NEPHRITIS; OBSERVATIONAL STUDY; PEDIATRICS; PHYSICIAN; PROSPECTIVE STUDY; PSYCHOMETRY; QUESTIONNAIRE; RHEUMATOLOGY; SCORING SYSTEM; SYSTEMIC LUPUS ERYTHEMATOSUS; VISUAL ANALOG SCALE;

CONSENSUS; COOPERATIVE BEHAVIOR; EUROPE; GREAT BRITAIN; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; RHEUMATOLOGY; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 80855151613     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/acr.20623     Document Type: Article

References (30)

1. Marks SD, Pilkington C, Woo P, Dillon MJ,. The use of the British Isles Lupus Assessment Group (BILAG) index as a valid tool in assessing disease activity in childhood-onset systemic lupus erythematosus. Rheumatology (Oxford) 2004; 43: 1186-9. (Pubitemid 39232827)
2. Brunner HI, Feldman BM, Bombardier C, Silverman ED,. Sensitivity of the Systemic Lupus Erythematosus Disease Activity Index, British Isles Lupus Assessment Group Index, and Systemic Lupus Activity Measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus. Arthritis Rheum 1999; 42: 1354-60. (Pubitemid 30265592)
3. Brunner HI, Higgins GC, Klein-Gitelman MS, Lapidus SK, Olson JC, Onel K, et al. Minimal clinically important differences of disease activity indices in childhood-onset systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2010; 62: 950-9.
4. Jaeschke R, Singer J, Guyatt GH,. Measurement of health status: ascertaining the minimal clinically important difference. Control Clin Trials 1989; 10: 407-15. (Pubitemid 20025670)
5. Symmons DP, Coppock JS, Bacon PA, Bresnihan B, Isenberg DA, Maddison P, et al. Development and assessment of a computerized index of clinical disease activity in systemic lupus erythematosus: members of the British Isles Lupus Assessment Group (BILAG). Q J Med 1988; 69: 927-37. (Pubitemid 19075365)
6. Yee CS, Cresswell L, Farewell V, Rahman A, Teh LS, Griffiths B, et al. Numerical scoring for the BILAG-2004 index. Rheumatology (Oxford) 2010; 49: 1665-9.
7. Pope J,. The revised BILAG Index with numerical scoring in systemic lupus erythematosus: added value with some limitations. Rheumatology (Oxford) 2010; 49: 1616-7.
8. Bencivelli W, Vitali C, Isenberg DA, Smolen JS, Snaith ML, Sciuto M, et al. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research III: development of a computerised clinical chart and its application to the comparison of different indices of disease activity. The European Consensus Study Group for Disease Activity in SLE. Clin Exp Rheumatol 1992; 10: 549-54.
9. Brunner HI, Silverman ED, Bombardier C, Feldman BM,. European consensus lupus activity measurement is sensitive to change in disease activity in childhood-onset systemic lupus erythematosus. Arthritis Rheum 2003; 49: 335-41. (Pubitemid 36682400)
10. Ruperto N, Ravelli A, Cuttica R, Espada G, Ozen S, Porras O, et al, for the Pediatric Rheumatology International Trials Organization (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG). The Pediatric Rheumatology International Trials Organization criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: prospective validation of the disease activity core set. Arthritis Rheum 2005; 52: 2854-64. (Pubitemid 41369116)
11. Ruperto N, Ravelli A, Oliveira S, Alessio M, Mihaylova D, Pasic S, et al. for the Pediatric Rheumatology International Trials Organization (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG). The Pediatric Rheumatology International Trials Organization/American College of Rheumatology provisional criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: prospective validation of the definition of improvement. Arthritis Rheum 2006; 55: 355-63. (Pubitemid 43887020)
12. Liang MH, Socher SA, Larson MG, Schur PH,. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989; 32: 1107-18. (Pubitemid 19237865)
13. Schned ES, Glickstein SL, Doyle MA,. Derivation of the SLEDAI [letter]. Arthritis Rheum 1993; 36: 877. (Pubitemid 23175635)
14. Gladman DD, Ibanez D, Urowitz MB,. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002; 29: 288-91. (Pubitemid 34118775)
15. Guzman J, Cardiel MH, Arce-Salinas A, Sanchez-Guerrero J, Alarcon-Segovia D,. Measurement of disease activity in systemic lupus erythematosus: prospective validation of 3 clinical indices. J Rheumatol 1992; 19: 1551-8.
16. Filocamo G, Davi S, Pistorio A, Bertamino M, Ruperto N, Lattanzi B, et al. Evaluation of 21-numbered circle and 10-centimeter horizontal line visual analog scales for physician and parent subjective ratings in juvenile idiopathic arthritis. J Rheumatol 2010; 37: 1534-41.
17. Brunner HI, Silverman ED, To T, Bombardier C, Feldman BM,. Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage. Arthritis Rheum 2002; 46: 436-44. (Pubitemid 34136581)
18. Ravelli A, Duarte-Salazar C, Buratti S, Reiff A, Bernstein B, Maldonado-Velazquez MR, et al. Assessment of damage in juvenile-onset systemic lupus erythematosus: a multicenter cohort study. Arthritis Rheum 2003; 49: 501-7. (Pubitemid 36988304)
19. Miettunen PM, Ortiz-Alvarez O, Petty RE, Cimaz R, Malleson PN, Cabral DA, et al. Gender and ethnic origin have no effect on longterm outcome of childhood-onset systemic lupus erythematosus. J Rheumatol 2004; 31: 1650-4. (Pubitemid 39006650)
20. Lilleby V, Flato B, Forre O,. Disease duration, hypertension and medication requirements are associated with organ damage in childhood-onset systemic lupus erythematosus. Clin Exp Rheumatol 2005; 23: 261-9. (Pubitemid 40663012)
21. Bandeira M, Buratti S, Bartoli M, Gasparini C, Breda L, Pistorio A, et al. Relationship between damage accrual, disease flares and cumulative drug therapies in juvenile-onset systemic lupus erythematosus. Lupus 2006; 15: 515-20. (Pubitemid 44289549)
22. Brunner HI, Feldman BM, Urowitz MB, Gladman DD,. Item weightings for the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Disease Damage Index using Rasch analysis do not lead to an important improvement. J Rheumatol 2003; 30: 292-7. (Pubitemid 36152592)
23. Rasch G,. An item analysis which takes individual differences into account. Br J Math Stat Psychol 1966; 19: 49-57.
24. Ruperto N, Buratti S, Duarte-Salazar, Pistorio A, Reiff A, Bernstein B, et al. Health-related quality of life in juvenile-onset systemic lupus erythematosus and its relationship to disease activity and damage. Arthritis Rheum 2004; 51: 458-64. (Pubitemid 38725148)
25. Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996; 39: 363-9. (Pubitemid 26085211)
26. Gladman DD, Urowitz MB, Goldsmith CH, Fortin P, Ginzler E, Gordon C, et al. The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index in patients with systemic lupus erythematosus. Arthritis Rheum 1997; 40: 809-13. (Pubitemid 27199995)
27. Gutierrez-Suarez R, Ruperto N, Gastaldi R, Pistorio A, Felici E, Burgos-Vargas R, et al. A proposal for a pediatric version of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index based on the analysis of 1,015 patients with juvenile-onset systemic lupus erythematosus. Arthritis Rheum 2006; 54: 2989-96. (Pubitemid 44497780)
28. Dayal NA, Gordon C, Tucker L, Isenberg DA,. The SLICC damage index: past, present and future. Lupus 2002; 11: 261-5. (Pubitemid 34506733)
29. Hiraki LT, Hamilton J, Silverman ED,. Measuring permanent damage in pediatric systemic lupus erythematosus. Lupus 2007; 16: 657-62. (Pubitemid 47360004)
30. Ravelli A, Ruperto N, Martini A,. Outcome in juvenile onset systemic lupus erythematosus. Curr Opin Rheumatol 2005; 17: 568-73. (Pubitemid 41527817)